XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)

NCT01178268 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

546

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Occlusion
Thrombosis (Stent Thrombosis)
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis
Coronary Disease
Coronary Artery Disease
Coronary Restenosis

Interventions

DEVICE: XIENCE V EECSS
DEVICE: CYPHER SELECT PLUS SECSS

Sponsor

Abbott Medical Devices